Virax Biolabs (VRAX) Assets (2021 - 2026)
Virax Biolabs (VRAX) posted quarterly Assets of $8.3 million for Q1 2026, up 29.53% year-over-year from $6.4 million in Q1 2025, and up 29.53% quarter-over-quarter from $6.4 million in Q1 2025.
Virax Biolabs (VRAX) Assets (2021 - 2026) Analysis & Trends
Virax Biolabs' Assets history runs 6 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- In Q1 2026, Assets rose 29.53% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (up 29.53% YoY), while the FY2026 annual figure was $8.3 million, up 29.53% from the prior year.
- Assets for Q1 2026 stood at $8.3 million, up from $6.4 million in the prior quarter.
- The five-year high for Assets was $9.8 million in Q1 2023, with the low at $48706.0 in Q1 2022.
- The 5-year median for Assets is $7.4 million (2025), against an average of $6.6 million.
- The sharpest annual moves came in 2023 and 2024: Assets jumped 20046.22% in 2023, then plunged 44.11% in 2024.
- Virax Biolabs' Assets stood at $48706.0 in 2022, then surged by 20046.22% to $9.8 million in 2023, then dropped by 3.77% to $9.4 million in 2024, then plunged by 31.94% to $6.4 million in 2025, then gained by 29.53% to $8.3 million in 2026.
- Business Quant data shows VRAX's Assets at $8.3 million in Q1 2026, $6.4 million in Q1 2025, and $9.4 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Virax Biolabs | 1.31 Mn | -5.13 Mn | - | 8.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.32 Mn |
| Mar 31, 2025 | 6.43 Mn |
| Sep 30, 2024 | 9.44 Mn |
| Mar 31, 2024 | 5.48 Mn |
| Mar 31, 2023 | 9.81 Mn |
| Mar 31, 2022 | 48,706.00 |
| Mar 31, 2021 | 39,621.00 |